SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 47 850 KRW -1.34% Market Closed
Market Cap: 3.7T KRW
Have any thoughts about
SK Bioscience Co Ltd?
Write Note

Relative Value

The Relative Value of one SK Bioscience Co Ltd stock under the Base Case scenario is 49 649.39 KRW. Compared to the current market price of 47 850 KRW, SK Bioscience Co Ltd is Undervalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
49 649.39 KRW
Undervaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
43
Median 3Y
12.8
Median 5Y
13
Industry
7.7
Forward
16.5
vs History
vs Industry
1
Median 3Y
68.9
Median 5Y
91.8
Industry
22.7
Forward
-72.7
vs History
vs Industry
3
Median 3Y
34.7
Median 5Y
37.2
Industry
21.6
vs History
vs Industry
Median 3Y
-21.3
Median 5Y
25.6
Industry
25.2
vs History
95
vs Industry
37
Median 3Y
3.3
Median 5Y
3.5
Industry
2.5
vs History
32
vs Industry
43
Median 3Y
9.9
Median 5Y
10.1
Industry
7.7
Forward
11.4
vs History
19
vs Industry
25
Median 3Y
21.2
Median 5Y
23.6
Industry
9
vs History
vs Industry
1
Median 3Y
31.6
Median 5Y
45
Industry
4.2
Forward
-54.7
vs History
vs Industry
0
Median 3Y
20.2
Median 5Y
23.2
Industry
4.1
Forward
-37
vs History
vs Industry
3
Median 3Y
28.3
Median 5Y
29.4
Industry
5.7
vs History
vs Industry
Median 3Y
-15.3
Median 5Y
20.9
Industry
3.6
vs History
95
vs Industry
32
Median 3Y
6.5
Median 5Y
7.1
Industry
4.6

Multiples Across Competitors

Competitors Multiples
SK Bioscience Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
SK Bioscience Co Ltd
KRX:302440
3.7T KRW 18.3 -85 -42 -26.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
KR
SK Bioscience Co Ltd
KRX:302440
Average P/E: 208.3
Negative Multiple: -85
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
SK Bioscience Co Ltd
KRX:302440
Average EV/EBITDA: 17.2
Negative Multiple: -42
21%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
KR
SK Bioscience Co Ltd
KRX:302440
Average EV/EBIT: 22.5
Negative Multiple: -26.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top